Mads Hald Andersen

Mads Hald Andersen

Clinical Professor

Member of:


    1. 2016
    2. Published

      GTn repeat polymorphism in heme oxygenase-1 (HO-1) correlates with clinical outcome after myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation

      Køllgaard, T., Kornblit, B., Petersen, J., Klausen, T. W., Mortensen, B. K., Brændstrup, P., Sengeløv, Henrik, Høgdall, Estrid Vilma Solyom, Muller, Klaus, Vindeløv, L., Andersen, Mads Hald & thor Straten, E. P., Dec 2016, In: PLoS ONE. 11, 12, 8 p., e0168210.

      Research output: Contribution to journalJournal articleResearchpeer-review

    3. Published

      The CALR exon 9 mutations are shared neoantigens in patients with CALR mutant chronic myeloproliferative neoplasms

      Holmström, M. O., Riley, C. H., Svane, Inge Marie, Hasselbalch, H. C. & Andersen, Mads Hald, Dec 2016, In: Leukemia. 30, 12, p. 2413-2416 14 p.

      Research output: Contribution to journalLetterResearchpeer-review

    4. Published

      mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma

      Borch, T. H., Engell-Noerregaard, L., Iversen, T. Z., Ellebaek, E., Met, Özcan, Hansen, M., Andersen, Mads Hald, thor Straten, E. P. & Svane, Inge Marie, 1 Sep 2016, In: OncoImmunology. 5, 9, 12 p., e1207842.

      Research output: Contribution to journalJournal articleResearchpeer-review

    5. Published

      Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21

      Hansen, M., Met, Özcan, Larsen, N. B., Rosenkilde, Mette, Andersen, Mads Hald, Svane, Inge Marie & Hjortø, Gertrud Malene, Sep 2016, In: Cytotherapy. 18, 9, p. 1187-1196

      Research output: Contribution to journalJournal articleResearchpeer-review

    6. Published

      PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine

      Munir Ahmad, S., Martinenaite, E., Hansen, M., Junker, N., Borch, T. H., Met, Özcan, Donia, M., Svane, Inge Marie & Andersen, Mads Hald, 2 Aug 2016, In: OncoImmunology. 5, 8, e1202391.

      Research output: Contribution to journalJournal articleResearchpeer-review

    7. Published

      Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen

      Andersen, R., Donia, M., Ellebæk, E., Borch, T. H., Kongsted, P., Iversen, T. Z., Hølmich, Lisbet Rosenkrantz, Hendel, Helle Westergren, Met, Özcan, Andersen, Mads Hald, Thor Straten, E. P. & Svane, Inge Marie, Aug 2016, In: Clinical Cancer Research. 22, 15, p. 3734-3745 12 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    8. Published

      Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab

      Bjørn, J., Iversen, T. Z., Nitschke, N. J., Andersen, Mads Hald & Svane, Inge Marie, Aug 2016, In: Cytotherapy. 18, 8, p. 1043-1055 13 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    9. Published

      PD-L1-specific T cells

      Ahmad, S. M., Borch, T. H., Hansen, M. & Andersen, Mads Hald, Jul 2016, In: Cancer Immunology, Immunotherapy. 65, 7, p. 797-804 8 p.

      Research output: Contribution to journalReviewResearchpeer-review

    10. Published

      Novel understanding of self-reactive T cells

      Andersen, Mads Hald, Mar 2016, In: OncoImmunology. 5, 3, 2 p., e1083672 .

      Research output: Contribution to journalEditorialResearchpeer-review

    11. Published

      Anti-regulatory T cells

      Andersen, Mads Hald, 2016, Københavns Universitet.

      Research output: Book/ReportDoctoral thesisResearch

    Previous 1 2 Next

    ID: 13571778